2022
Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention
Coy KC, Ko JY, Ondersma SJ, Gilstad-Hayden K, Zapata LB, Chang G, Yonkers K. Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention. Journal Of Women's Health 2022, 31: 1630-1638. PMID: 35352988, PMCID: PMC10970710, DOI: 10.1089/jwh.2021.0483.Peer-Reviewed Original ResearchConceptsSubstance use disordersSubstance usePregnancy timingUse disordersRobust error varianceConfidence intervalsPrenatal care sitesPostpartum carePregnancy intentionPrevalence ratiosIntended pregnanciesCare sitesPoisson regressionSecondary analysisIndependent relationshipPregnancyRelevant covariatesTotal sample sizeFamily planningWomenAssociationDisordersSupport Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics
Forray A, Mele A, Byatt N, Tobon A, Gilstad-Hayden K, Hunkle K, Hong S, Lipkind H, Fiellin DA, Callaghan K, Yonkers KA. Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics. PLOS ONE 2022, 17: e0261751. PMID: 35025898, PMCID: PMC8758001, DOI: 10.1371/journal.pone.0261751.Peer-Reviewed Original ResearchConceptsOpioid use disorderPregnant womenUse disordersPrenatal clinicsClinical trialsReproductive health cliniciansCollaborative care approachTRIAL REGISTRATION NUMBERCommunity Healthcare OutcomesMatched-pair clusterPatient treatment engagementTreatment modelObstetric providersOUD treatmentPrimary outcomeObstetrical providersPostpartum womenHealth cliniciansCare approachRegistration numberTreatment engagementRelated treatmentsHealthcare outcomesTrialsWomen
2021
The Collision of Mental Health, Substance Use Disorder, and Suicide
Forray A, Yonkers KA. The Collision of Mental Health, Substance Use Disorder, and Suicide. Obstetrics And Gynecology 2021, 137: 1083-1090. PMID: 33957654, DOI: 10.1097/aog.0000000000004391.Peer-Reviewed Original ResearchConceptsRisk of suicideSubstance use disordersUse disordersMental healthPerinatal periodSuicidal thoughtsReproductive health care clinicsSevere perinatal depressionHealth care clinicsCause of deathWomen's mental healthPerinatal depressionCare clinicsPerinatal womenPregnant womenDepressive episodeReproductive yearsPsychiatric illnessAmerican CollegePsychiatric disordersCareful monitoringPsychiatric conditionsSuicide attemptsChildhood adversitySuicide prevention
2020
Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients
Serowik KL, Yonkers KA, Gilstad-Hayden K, Forray A, Zimbrean P, Martino S. Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients. Journal Of General Internal Medicine 2020, 36: 668-675. PMID: 33111239, PMCID: PMC7947066, DOI: 10.1007/s11606-020-06319-7.Peer-Reviewed Original ResearchConceptsSubstance use disordersUse disordersMedical inpatientsPatient characteristicsMedical recordsGeneral medical inpatient unitsPatient self-report questionnairesGeneral medical inpatientsMedical inpatient unitsOpioid use disorderDrug use disordersNicotine use disorderPatients' medical recordsCannabis use disorderLarge teaching hospitalAlcohol use disorderDetection rateCocaine use disorderWhite patientsBlack patientsFemale patientsHispanic patientsFormal screeningInpatient providersTeaching hospitalInpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders
Joudrey PJ, Oldfield BJ, Yonkers KA, O'Connor PG, Berland G, Edelman EJ. Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders. Drug And Alcohol Dependence 2020, 213: 108090. PMID: 32559667, PMCID: PMC7375447, DOI: 10.1016/j.drugalcdep.2020.108090.Peer-Reviewed Original ResearchIntervention characteristicsUrban academic medical centerLarge urban academic medical centerHealth professionals' knowledgeCharacteristics of individualsMixed-methods formative evaluationAcademic medical centerAlcohol use disorderStigma of peopleClinical evidencePatient preferencesInpatient settingMedical CenterTreatment goalsImplementation interventionsPrescribing professionalsPatient vulnerabilitySide effectsUse disordersOuter settingHealth professionalsInner settingConsolidated FrameworkCFIR constructsOrganizational prioritization
2019
Identification of substance use disorders among pregnant women: A comparison of screeners
Chang G, Ondersma SJ, Blake-Lamb T, Gilstad-Hayden K, Orav EJ, Yonkers KA. Identification of substance use disorders among pregnant women: A comparison of screeners. Drug And Alcohol Dependence 2019, 205: 107651. PMID: 31683243, DOI: 10.1016/j.drugalcdep.2019.107651.Peer-Reviewed Original ResearchConceptsSubstance use disordersPregnant womenUse disordersAlcohol use disorderDrug use questionnaireMINI diagnostic interviewRate of useMean ageDiagnostic criteriaQuick screenDiagnostic InterviewIdeal questionnaireCRAFFTDisordersWomenModest abilityReference standardUse QuestionnaireQuestionnaireScreener
2017
CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome
Ko JY, Wolicki S, Barfield WD, Patrick SW, Broussard CS, Yonkers KA, Naimon R, Iskander J. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morbidity And Mortality Weekly Report 2017, 66: 242-245. PMID: 28278146, PMCID: PMC5687191, DOI: 10.15585/mmwr.mm6609a2.Peer-Reviewed Original ResearchConceptsNeonatal abstinence syndromeMedication-assisted treatmentPrescription opioidsAbstinence syndromeCentral nervous system irritabilityDrug withdrawal syndromeOpioid use disorderHours of birthPublic health strategiesGastrointestinal dysfunctionOpioid exposurePain reliefWithdrawal syndromeUtero exposureClinical signsHealth strategiesUse disordersSyndromeOpioidsIllicit useExposurePregnancyDysfunctionInfantsIrritability
2014
Progesterone for the reduction of cocaine use in post-partum women with a cocaine use disorder: a randomised, double-blind, placebo-controlled, pilot study
Yonkers KA, Forray A, Nich C, Carroll KM, Hine C, Merry BC, Shaw H, Shaw J, Sofuoglu M. Progesterone for the reduction of cocaine use in post-partum women with a cocaine use disorder: a randomised, double-blind, placebo-controlled, pilot study. The Lancet Psychiatry 2014, 1: 360-367. PMID: 25328863, PMCID: PMC4199242, DOI: 10.1016/s2215-0366(14)70333-5.Peer-Reviewed Original ResearchCocaine use disorderCocaine usePostpartum womenPost trialUse disordersPlacebo-controlled pilot trialOral micronized progesteronePositive urine testPost-partum womenGroup differencesSelf-reported daysMultiple brain functionsUse of cocaineMicronized progesteroneObstetrical clinicTherapeutic breakProgesterone replacementAdverse eventsUS National InstitutesProgesterone treatmentUrine testsPilot trialRate of submissionStudy biostatisticianProgesterone
2001
An Eight-Year Longitudinal Comparison of Clinical Course and Characteristics of Social Phobia Among Men and Women
Yonkers KA, Dyck IR, Keller MB. An Eight-Year Longitudinal Comparison of Clinical Course and Characteristics of Social Phobia Among Men and Women. Psychiatric Services 2001, 52: 637-643. PMID: 11331798, DOI: 10.1176/appi.ps.52.5.637.Peer-Reviewed Original ResearchConceptsHealth-related qualityHarvard/Brown Anxiety Research ProgramSuicide attemptsSocial phobiaComorbid substance use disorderPoorer baseline functioningLower Global AssessmentPercent of menPercent of womenSubstance use disordersPotential sex differencesComplete remissionRemission rateClinical courseChronic courseEight-year study periodChronic disordersHigh prevalenceObservational studyFunctioning scoresUse disordersBaseline functioningConcurrent agoraphobiaGreater chronicityGlobal assessment